Port, shipping firms divert vessels after a Ningbo terminal shuts… After 1 infection

China partly shut the world’s third-busiest container port after a ONE worker became infected with COVID-19, threatening more damage to already fragile supply chains and global trade as a key shopping season nears. All inbound and outbound container services at Meishan terminal (worlds third largest) in Ningbo-Zhoushan port were halted Wednesday until further notice due to a “system disruption,” according to a statement from the port. An employee tested positive for coronavirus, the eastern Chinese city’s government said. The closed terminal accounts for about 25% of container cargo through the port, calculates security consultant GardaWorld, which said “the suspension could severely impact cargo handling and shipping.” Germany’s Hapag-Lloyd AG said there will be a delay in sailings. This is the second recent shutdown of a Chinese port due to the coronavirus, after the closure of Yantian port in Shenzhen from late May for about a month. The action led goods to back up in factories and storage yards and also likely lifted soaring freight rates, which are at record levels and a source of inflation.

The fear is that this new disruption will further strain shipping and supplies of goods, dampening growth and driving up prices. An extended shuttering at Ningbo could be especially painful for the world economy because seaborne trade usually rises toward the end of the year as companies ship Christmas and holiday products.

“There may be far-reaching downstream consequences going into Black Friday and holiday shopping seasons” and the next 24 hours will determine whether there is a large outbreak or not, said Josh Brazil, vice president of marketing at project44, a supply-chain intelligence firm. “One of the few givens in 2021 is endemic delays, and the fact that conditions can change almost overnight.” In addition to the closed terminal, containers for shipment through the other terminals in the port will likely slow. The port will now only accept containers within two days of a ship’s estimated arrival time, according to a statement from shipping and logistics firm CMA CGM SA. The biggest exports through Ningbo in the first half of this year were electronic goods, textiles and low and high-end manufactured goods, according to the city’s Customs Bureau. Top imports included crude oil, electronics, raw chemicals and agricultural products.

China: No need for further WHO COVID origin probe of the greatest conspiracy of our time

China on Friday rejected the World Health Organization’s calls for a renewed probe into the origins of Covid-19, saying it supported “scientific” over “political” efforts to find out how the virus started. Pressure is once more mounting on Beijing to consider a fresh probe into the origins of a pandemic which has killed more than four million people and paralysed economies worldwide since it first emerged in the central Chinese city of Wuhan. A delayed and heavily politicised visit by a WHO team of international experts went to Wuhan in January 2021 to produce a first phase report, which was written in conjunction with their Chinese counterparts. It failed to conclude how the virus began. On Thursday the WHO urged China to share raw data from the earliest Covid-19 cases to revive its probe into the origins of the disease. China hit back, Vice Foreign Minister Ma Zhaoxu saying it has never rejected cooperation on tracing the origins of Covid-19, but rejects the politicisation of such a search, state media reported. “We oppose political tracing … and abandoning the joint report” issued after the WHO team’s Wuhan visit, Ma told reporters. “We support scientific tracing.” The joint report said the virus jumping from bats to humans via an intermediate animal was the most probable scenario, while a leak from Wuhan’s virology labs was “extremely unlikely”. Ma rejected suggestions of new lines of investigation. “The conclusions and recommendations of WHO and China joint report were recognised by the international community and the scientific community,” he said. “Future global traceability work should and can only be further carried out on the basis of this report, rather than starting a new one.” China is continuing to conduct “follow-up and supplementary” research into the origins of the novel coronavirus as specified in the joint report, Ma said. The WHO on Thursday called for all governments to cooperate to accelerate studies into the origins of the pandemic and “to depoliticise the situation”. In the face of China’s reluctance to open up to outside investigators, experts are increasingly open to considering the theory that the virus might have leaked from a lab, once dismissed as a conspiracy propagated by the US far right. Even WHO chief Tedros Adhanom Ghebreyesus has said that the initial probe into Wuhan’s virology labs had not gone far enough, while US President Joe Biden in May ordered a separate investigation into the virus origins from the US intelligence community. A WHO call last month for the investigation’s second stage to include audits of the Wuhan labs infuriated Beijing, with Vice Health Minister Zeng Yixin saying the plan showed “disrespect for common sense and arrogance towards science”. Meanwhile, Danish scientist Peter Ben Embarek, who led the international mission to Wuhan, said a lab employee infected while taking samples in the field falls under one of the likely hypotheses as to how the virus passed from bats to humans.

He told the Danish public channel TV2 that the suspect bats were not from the Wuhan region and the only people likely to have approached them were workers from the Wuhan labs.

Ben Embarek previously acknowledged in an interview with Science magazine that “politics was always in the room with us” during the Wuhan trip, which was mired in delays after China initially stalled approval for the international researchers’ entry.

Fauci: Likely everyone will need booster jab shot

NIAID director Anthony Fauci told “CBS This Morning” on Thursday that it is “likely” everyone will need a vaccine booster shot in the future, but apart from the immune compromised, “we don’t feel a need to give boosters right now.” The FDA is expected to update its emergency use authorization for the Pfizer and Moderna coronavirus vaccines as early as Thursday to allow immunocompromised people to get a third dose, Scientists don’t agree who should receive booster shots and when, especially as much of the world’s population is still waiting for their initial round of shots, Axios’ Caitlin Owens report Research shows that the vaccines are losing some potency against milder infections, causing concern as data also suggest that people with breakthrough cases can effectively transmit the virus. “We’re already starting to see indications in some sectors about a diminution over time, that’s durability,” Fauci said. “We don’t feel at this particular point, that apart from the immune compromised, we don’t feel we need to give boosters right now,” he added. Fauci said that data is being followed “literally on a weekly and monthly basis” to determine how the level of protection is diminishing.

Coronavirus surge pushes Cuba’s healthcare system to brink

HAVANA (Reuters) – Cuba is bringing back hundreds of doctors working abroad and converting hotels into isolation centers and hospitals in order to battle a COVID-19 crisis that is overwhelming healthcare and mortuary services in parts of the Caribbean island. The country, which managed to contain infections for most of last year, is now facing one of the worst outbreaks worldwide, fueled by the spread of the more-infectious Delta variant, even as it races to vaccinate its population. Cuba’s rolling seven-day average of confirmed COVID-19 cases has surged eightfold within two months to 5,639 per million inhabitants, ten times the world average. One in five tests are positive, four times the benchmark 5% positivity rate cited by the World Health Organization. The seven-day average for confirmed COVID-19 deaths is around 52 per million inhabitants, six times the world average, although the real number could be much higher accounting for potentially undiagnosed cases. The COVID-19 surge has come amid Cuba’s worst economic crisis in decades that had already resulted in medicine shortages and long queues for scarce goods that made implementing lockdowns tricky. The predicament has come as a shock to some in the Communist-run country where the right to public healthcare is considered sacrosanct. “I witnessed queues of more than 20 hours, people dying in the corridors (of the polyclinic),” wrote Ana Iris Diaz, a professor at the university of the central Cuban city of Santa Clara and self-professed “revolutionary”, in a Facebook post that went viral this week. “I saw an elderly woman die after several hours of waiting and four days without an antigen test or PCR. Simply put, I saw what I would have hoped to never see: the collapse of our health system.” Cuba’s Communist government did not reply to a request for comment. It has denounced the United States for tightening sanctions, saying this has also slowed down its vaccine rollout due to the difficulty of acquiring inputs. Critics blame more Cuba’s inefficient state-run economy. Deaths in Cuba since the start of the pandemic are still only a half of the global average, according to official data. The death toll is rising fast though. In the eastern province of Guantanamo, artist Daniel Ross said a 30-year-old friend of his who caught COVID-19 had recently died due to a lack of medicines and oxygen. “Here, we fight COVID-19 with Azitromicina, which costs 16 pesos usually in the pharmacy, but they haven’t had any for months now,” he said, adding that the cost had surged to 3600 pesos, equivalent to $150 on the black market. Also infected and struggling to breathe, he said he was doing inhalations with yagruma leaves but sometimes could not even heat water because of the power outages that have become more frequent lately. Ihosvany Fernandez, director of communal services in the province of Guantanamo, said on local television that total deaths there, from any cause, had surged at the start of the month to more than 60 per day from around 12 on average usually. Official data show no more than 10 COVID-19 death daily in Guantanamo for those days suggesting underreporting in deaths from the respiratory disease. One of the province’s incinerators had broken down due to overuse, said Fernandez, so they were installing another and using a variety of state vehicles to transport the corpses given insufficient hearses. So far, a quarter of Cuba’s 11.2 million inhabitants have been innoculated with its two most advanced vaccines that officials say have proven more than 90 % effective in phase three trials. In one bright spot, the case-fatality rate in Havana, where nearly two thirds of the population has now been fully innocculated, was just 0.69 % compared to 0.93% for the rest of the country in the first week of August, according to official data, suggesting the shots are working.

S. Korea biggest daily spike 2,223 new COVID-19 cases

South Korea on Wednesday confirmed more new cases of COVID-19 in a single day than it has seen so far during this pandemic. Making matters even more concerning, experts say the coming weeks could be even worse. This is the first time that the country has logged more than 2-thousand Covid-19 infections in a single 24-hour period.
South Korea on Wednesday reported 2,223 new Covid-19 infections. The greater Seoul area saw the highest number of local infections yet, with the local caseload at 1,405.Health authorities say the Delta variant is driving up cases, with clusters erupting in workplaces, indoor sports facilities, churches, and at care hospitals.
But the worst is yet to come.

Experts last month have already projected that at the virus’ current reproductive rate,.. the nation will see 2,5-hundred to 3-thousand new cases a day by late August.

Experts are also worried about the enormous strain this will put on healthcare services, saying a sudden rise could overwhelm medical staff and supplies. In that case, what can be done – that hasn’t already been attempted – to try and curb the spread. Health authorities say that in order to protect our lives and the economy, we first need to decrease the risk of infection by cutting down on travel and social gatherings. But we can’t only rely on social distancing to fix the problem. Vaccinations are of the utmost importance as well. “We need to do our best to protect the most vulnerable people and facilities by curbing the infection spread through prevention methods, and also by raising the vaccination rates.” There will be a boost in the supply of Pfizer’s vaccines today, with six million additional doses arriving.

Top Japan health adviser wants stricter COVID-19 measures for about two weeks

OKYO -Japan’s top health adviser said on Thursday he would request stricter emergency measures for about two weeks to tackle a spike in COVID-19 cases in Tokyo and other areas.

Shigeru Omi told reporters the contagion should treated as a natural disaster and he called on the government to increase testing to find and contain the spread.

A few days after the end of the Tokyo Olympics, the capital reported 4,989 new daily cases on Thursday, down slightly from record 5,042 last week. The new number of patients with serious symptoms increased to an all-time daily high of 218. There has been no evidence that the Olympics https://www.usnews.com/news/top-news/articles/2021-08-07/olympics-tokyo-feared-games-would-spread-covid-numbers-suggest-that-didnt-happen directly increased case numbers in Japan, but health experts have warned that holding the Games could have encouraged people to relax infection controls. Japan is vaccinating more than 1 million people a day, but it still lags many major economies in inoculating its population. Tokyo is already under a state of emergency, the fourth so far in the pandemic, though some experts have said it should be expanded to cover the whole country. The western prefecture of Osaka reported a record 1,654 new cases on Thursday. Hospital beds are filling up rapidly, mainly with patients in their 40s and 50s, Omi said. To try to break the chain of infection, he said, authorities should try to reduce human mobility to about 50% of the average in July. His comments echoed those of a separate panel of experts who said on Thursday contagion in Tokyo had become uncontrollable.

“The number of new positive cases is rapidly increasing, making it impossible to control the situation,” Norio Ohmagari, a health adviser to the Tokyo Metropolitan Government, told a panel chaired by Governor Yuriko Koike.

Koike urged residents to avoid travel and stay home to slow the transmission of COVID-19, which is causing hospitals to have to forego some standard medical care.

WHO: Global virus cases to top 300M in early 2022

The World Health Organization (WHO) warned on Wednesday the global count of infections from COVID-19 will surpass 300 million in early 2022 if the pandemic continues to move in its current direction. WHO Director-General Tedros Adhanom Ghebreyesus stressed the real number of cases is “much higher” as there are many unreported ones. He also called for an urgent donation worth $7.7 billion of vaccines and medical supplies for lower-income countries. “We are all in this together. But the world is not acting like it,” Tedros said. Tedros recently commented on the new spikes in infections around the globe by saying that “hard-won gains in fighting COVID-19 are being lost.”

Director-General of the World Health Organization, Tedros Adhanom, warned on Friday that the number of newly registered COVID-19 cases and deaths continues to climb in numerous countries across the globe. Commenting on new coronavirus variants, Dr. Tedros argued there will be more versions of the virus as long as the spreading lasts. “Hard-won gains in fighting COVID-19 are being lost,” he insisted at WHO’s press briefing. Dr. Tedros concluded by reiterating that the WHO’s goal remains to support every country to vaccinate at least 40% of its population by the end of the year and 70% by the middle of 2022.

New data on coronavirus vaccine effectiveness

A new preprint study (copy below) that raises concerns about the mRNA vaccines’ effectiveness against Delta — particularly Pfizer’s — has already grabbed the attention of top Biden administration officials.

The study found the Pfizer vaccine was only 42% effective against infection in July, when the Delta variant was dominant. “If that’s not a wakeup call, I don’t know what is,” a senior Biden official told Axios.

The study, conducted by nference and the Mayo Clinic, compared the effectiveness of the Pfizer and Moderna vaccines in the Mayo Clinic Health System over time from January to July.

  • Overall, it found that the Moderna vaccine was 86% effective against infection over the study period, and Pfizer’s was 76%. Moderna’s vaccine was 92% effective against hospitalization and Pfizer’s was 85%.
  • But the vaccines’ effectiveness against infection dropped sharply in July, when the Delta variant’s prevalence in Minnesota had risen to over 70%.
  • Moderna was 76% effective against infection, and Pfizer was only 42% effective.
  • The study found similar results in other states. For example, in Florida, the risk of infection in July for people fully vaccinated with Moderna was about 60% lower than for people fully vaccinated with Pfizer.

Although it has yet to be peer-reviewed, the study raises serious questions about both vaccines’ long-term effectiveness, particularly Pfizer’s.

  • It’s unclear whether the results signify a reduction in effectiveness over time, a reduced effectiveness against Delta, or a combination of both.
  • “Based on the data that we have so far, it is a combination of both factors,” said Venky Soundararajan, a lead author of the study. “The Moderna vaccine is likely — very likely — more effective than the Pfizer vaccine in areas where Delta is the dominant strain, and the Pfizer vaccine appears to have a lower durability of effectiveness.”
  • He added that his team is working on a follow-up study that will try to differentiate between the durability of the two vaccines and their effectiveness against Delta.

Yes, but: There has been no data so far that has found either vaccine’s protection against severe disease and death is significantly less against Delta, and the study notes that there doesn’t appear to be much of a difference in complications stemming from breakthrough infections based on which vaccine someone got.

  • And experts cautioned against rushing to conclusions.
  • “This is the kind of surprising finding that needs confirmation before we should accept its validity,” said Cornell virologist John Moore.

Between the lines: The two shots both use mRNA, but there are significant differences between them.

  • For example, Moderna is given in a stronger dose than Pfizer, and there is a slightly different time interval between shots.
  • “There are a few differences between what are known to be similar vaccines …. None of these variables is an obvious smoking gun, although the dosing amount seems the most likely to be a factor,” Moore said.

In a statement, Pfizer said it and BioNTech “expect to be able to develop and produce a tailor-made vaccine against that variant in approximately 100 days after a decision to do so, subject to regulatory approval.” Nick Note: Now will you listen to me… It’s foolish to have a librarian that sees the future and not use your library card. Bottom line get a booster shot NOW… and initiate our personnel protection protocols. Mask up, Vitamin up, isolate, TEST EVERYONE WHO COMES INTO YOUR AIRSPACE. Read the study for yourself below

2021.08.06.21261707v2.full

To Order Test kits, CoronaVits and mask/filters click the link below.

ORDER NOW

Experts Predict What The Next COVID-19 Variants Will Be Like

Alpha, beta, gamma, delta — there have been four COVID-19 variants of concern that have altered the course of the pandemic at different points in the past year and a half. First came the alpha variant, first detected in the United Kingdom, that was more transmissible and caused the surges behind the winter wave of the pandemic. The beta variant came next, triggering outbreaks in South Africa, along with gamma, the variant that took hold of Brazil in January. Now we have delta ― definitely more transmissible, potentially more virulent (though it’s hard to know for sure), and a huge problem for those who remain unvaccinated. Every day brings new concerning headlines about this variant or that mutation, which brings up the natural question: What’s next? To better understand what the next round of variants might look like, we need to take a look at what we’ve learned so far about how this coronavirus changes. Each time the virus infects a new cell, it starts to makes copies of itself — and as it copies, it makes random changes (known as mutations) all over the place. Most mutations aren’t useful and die out, but some can be tolerated and passed on, said Ben Neuman, chief virologist at Texas A&M University’s Global Health Research Complex. Coronaviruses are typically slow changers — they mutate, as any virus does, but they don’t evolve at an alarming rate.

What shocked scientists is the rate of evolution, or how quickly these variants of concern acquired new mutations, according to Nathan Grubaugh, an evolutionary virologist and associate professor of epidemiology at the Yale School of Public Health.

In general, the coronavirus acquires about one or two mutations a month. But the variants of concern have acquired many more mutations much more quickly. Alpha, for example, didn’t just acquire one or two mutations, it picked up 17. The leading hypothesis is that it took a prolonged infection ― probably in an immunocompromised person whose body had a tough time clearing out the virus ― to collect this many mutations so rapidly. From there, the virus spread to somebody else before taking off and shooting through entire communities. According to Grubaugh, the same sort of rapid increase in mutations was identified with the beta variant detected in South Africa and the gamma variant that popped up in Brazil. “This phenomenon that we’re watching, of these variants that arise very quickly, I think caught a lot of us off guard,” Grubaugh said. It’s impossible to predict exactly what future variants will look like, but it’s pretty undeniable that we are going to see new variants emerge. “We haven’t seen the end of variants and we certainly haven’t seen the end of variants that are more transmissible,” Grubaugh said. The development of new variants that rise to the level of concern is actually extremely rare. There have probably been hundreds of thousands of events where a host of new mutations have occurred, but those versions of the virus weren’t very fit so they died out before becoming a variant of concern. Just because the virus evolves, doesn’t mean it’s going to become a variant of concern.

But, when you give the virus so many different opportunities to infect new people, it will inevitably test out new variations. As long as there are people for SARS-CoV-2 to infect, the coronavirus will continue to evolve.

“We know that most of the variants we see emerge from people who are not vaccinated,” said Dirk Dittmer, a virologist at the University of North Carolina’s School of Medicine who is currently working on a variant tracking project in North Carolina. We’ve never seen anything like SARS-CoV-2 before. We’ve never had a pandemic of this scale with so much global mixing. A variant that pops up in Brazil can be in Japan or the United States in a moment’s notice, Grubaugh said. What happens around the globe is going to impact the rest of the world — we aren’t living in a vacuum. This makes it a lot harder to predict what’s going to emerge and where. All that said, the scientists who study the evolution of viruses have some theories. Grubaugh said the next generation of variants could be just like delta, but better at what they do — probably more transmissible, maybe a little bit more successful at reinfecting people who were previously diagnosed with COVID-19. (We know the vaccines produce a more robust immune response than natural infection does.) Neuman predicts somewhat the same. In July, scientists identified that 90% of the SARS-CoV-2 genomes were in the genetic group that fell under the delta variant. Because of that, “the most likely bet is that future strains will look like delta, but with extra changes,” Neuman said.

Gamma and delta both are slightly better at evading immunity compared to alpha and the other earlier variants. To Neuman, it seems reasonable to speculate that the current versions of the vaccines we’re using will eventually be less effective against newer variants.

Continue reading “Experts Predict What The Next COVID-19 Variants Will Be Like”

Oil drops on China fuel demand concerns as Delta coronavirus surges

MELBOURNE/SINGAPORE, Aug 11 (Reuters) – Oil prices dipped on Wednesday as analysts cut their forecasts for fuel demand in China following mobility curbs from the spread of the highly infectious Delta variant of the coronavirus, offsetting a bullish outlook for U.S. fuel demand. U.S. West Texas Intermediate (WTI) crude futures fell 18 cents, or 0.3%, to $68.11 a barrel at 0500 GMT, after a 2.7% jump on Tuesday. Brent crude futures dropped 16 cents to $70.47 a barrel, following a 2.3% gain on Tuesday. While both contracts have reclaimed their 100-day daily moving average, a technical chart indicator, they appeared to lack the momentum to stage meaningful revivals as Delta variant fears continued to weigh on markets, said Jeffrey Halley, OANDA’s senior market analyst for Asia Pacific. “Short-term momentum has waned quickly in Asia,” he added. Beijing has imposed travel curbs that will reduce fuel demand in the world’s second-largest oil consumer, prompting Goldman Sachs to cut its demand forecast for China by 1 million barrels per day for the next two months. “Our base case remains that the Delta wave will impact demand – including in China – for only two months, consistent with prior cycles, including most recently in India,” the bank said. Industry data showed U.S. crude oil and gasoline inventories fell last week, while the U.S. Energy Information Administration raised its forecast for fuel demand in 2021 and said consumption in May through July was higher than expected, supporting prices. U.S. crude stocks fell by 816,00 barrels and gasoline stocks fell by 1.1 million barrels in the week ended Aug. 6, according to two market sources, citing data from the American Petroleum Institute. Both drawdowns were a bit smaller than analysts polled by Reuters had expected. The EIA’s monthly report showed that the need for supply from the Organization of the Petroleum Exporting Countries (OPEC) will exceed OPEC supply by 1 million barrels per day in the third quarter and by 300,000 bpd in the fourth quarter of 2021, Commonwealth Bank commodity analyst Vivek Dhar said in a note. “With OECD commercial crude oil stockpiles having dropped back to pre‑COVID levels already, a tightening oil market outlook will likely amplify oil price gains,” he said.